Epigral

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE071N01016
  • NSEID: EPIGRAL
  • BSEID: 543332
INR
929.85
-14.65 (-1.55%)
BSENSE

Nov 20

BSE+NSE Vol: 45.47 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Fineotex Chem
Yasho Industries
Tatva Chintan
Foseco India
Bhansali Engg.
Laxmi Organic
Vishnu Chemicals
Styrenix Perfor.
Epigral
Prasol Chemicals
Jubilant Agri
Why is Epigral Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -8.55% of over the last 5 years
2
Flat results in Sep 26
  • PAT(Latest six months) At Rs 164.82 cr has Grown at -22.22%
  • ROCE(HY) Lowest at 14.66%
  • INTEREST(Q) At Rs 10.78 cr has Grown at 49.31%
3
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 29-Oct-26 and has generated 2.92% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -0.71% over the previous quarter and collectively hold 5.91% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Below par performance in long term as well as near term
  • Along with generating -36.16% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Epigral for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Epigral
-36.16%
-0.80
45.30%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.50%
EBIT Growth (5y)
-8.55%
EBIT to Interest (avg)
8.45
Debt to EBITDA (avg)
1.35
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.97
Tax Ratio
26.09%
Dividend Payout Ratio
6.50%
Pledged Shares
0
Institutional Holding
5.91%
ROCE (avg)
21.66%
ROE (avg)
22.35%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
14
Industry P/E
37
Price to Book Value
1.69
EV to EBIT
11.00
EV to EBITDA
7.78
EV to Capital Employed
1.56
EV to Sales
1.64
PEG Ratio
NA
Dividend Yield
0.54%
ROCE (Latest)
14.18%
ROE (Latest)
12.05%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
DEBT-EQUITY RATIO(HY)

Lowest at 0.24 times

NET SALES(Q)

Highest at Rs 745.99 cr

-8What is not working for the Company
PAT(Latest six months)

At Rs 164.82 cr has Grown at -22.22%

ROCE(HY)

Lowest at 14.66%

INTEREST(Q)

At Rs 10.78 cr has Grown at 49.31%

PBT LESS OI(Q)

At Rs 81.76 cr has Fallen at -8.3% (vs previous 4Q average

Loading Valuation Snapshot...
Here's what is working for Epigral
Net Sales - Quarterly
Highest at Rs 745.99 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.24 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Epigral
Interest - Quarterly
At Rs 10.78 cr has Grown at 49.31%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Profit After Tax (PAT) - Latest six months
At Rs 164.82 cr has Grown at -22.22%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is negative

PAT (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 81.76 cr has Fallen at -8.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 89.17 Cr
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Non Operating Income - Quarterly
Highest at Rs 5.82 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income